| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.vivanzabiosciences.com | |
| Market Cap | 58.50 Cr. | |
| Enterprise Value(EV) | 66.25 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.26 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 116.53 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 45.42 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 10.48 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 13.95 | Calculated using Price: 146.25 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.40 Cr. | 4,000,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company is engaged in the business of business of Pharmaceutical Products. | ||
| 1 Day |
|
+2.20% |
| 1 Week |
|
-1.18% |
| 1 Month |
|
-10.71% |
| 3 Month |
|
+2.27% |
| 6 Month |
|
-25.00% |
| 1 Year |
|
-9.16% |
| 2 Year |
|
-13.97% |
| 5 Year |
|
+104.69% |
| 10 Year |
|
+411.36% |
| 7 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | -242.60 | -17.54 | 5.66 | -12.56 | -6.46 | 2.41 | 10.01 | |
| Return on Capital Employed (%) | -11.38 | -10.82 | 12.73 | -0.40 | 5.74 | 17.11 | 15.64 | |
| Return on Assets (%) | -9.49 | -7.99 | 2.37 | -4.15 | -1.75 | 0.72 | 3.13 |
| Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 0 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | |
| Non Curr. Liab. | 0 | 1 | 1 | 0 | 3 | 2 | |||
| Curr. Liab. | 1 | 3 | 6 | 7 | 9 | 5 | 7 | 8 | |
| Minority Int. | |||||||||
| Equity & Liab. | 1 | 7 | 10 | 11 | 12 | 8 | 13 | 13 | |
| Non Curr. Assets | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |
| Curr. Assets | 0 | 4 | 7 | 8 | 9 | 5 | 10 | 10 | |
| Misc. Exp. not W/O | |||||||||
| Total Assets | 1 | 7 | 10 | 11 | 12 | 8 | 13 | 13 |
| Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 3 | 6 | 3 | 10 | 10 | 10 | 15 | ||
| Other Income | 0 | 1 | 1 | 1 | 1 | ||||
| Total Income | 4 | 6 | 3 | 10 | 10 | 11 | 16 | ||
| Total Expenditure | 0 | -4 | -6 | -3 | -10 | -10 | -10 | -15 | |
| PBIDT | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Depreciation | 0 | 0 | 0 | ||||||
| Taxation | 0 | 0 | |||||||
| Exceptional Items | 0 | ||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
| Minority Interest | |||||||||
| Share Associate | |||||||||
| Other Related Items | |||||||||
| Consolidated Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
| Adjusted EPS | -3 | -1 | 1 | -1 | -1 | 0 | 1 | 1 |
| Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | 0 | 1 | 3 | -3 | |||
| Cash Fr. Inv. | 2 | 0 | ||||||
| Cash Fr. Finan. | 0 | -1 | -1 | -3 | 2 | |||
| Net Change | 0 | -1 | 0 | 0 | 0 | |||
| Cash & Cash Eqvt | -2 | -3 | -3 | -3 | -3 |
|
Wed, 01 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Dear Sir/Madam Pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith the copies of newspaper advertisement published today i.e. Wednesday February 01 2023 in Indian Express (English) and Financial Express (Gujarati) edition regarding Notice of Extra-Ordinary General Meeting Remote E-Voting Book Closure and Cut-off date published The above information is also available on the website of the Company: www.vivanzabiosciences.com |
|
Wed, 01 Feb 2023
Notice Of The Extraordinary General Meeting (EOGM) Will Be Held On Friday February 24 2023 This is to inform you that in compliance with relevant circulars issued by Ministry of Corporate Affairs and the Securities Exchange Board of India the Extra-Ordinary General Meeting ("EOGM") of the Company will be held on Friday February 24 2023 at 3:00 P.M. through Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The copy of the Notice of EGM is enclosed herewith for your kind reference.The Notice of EOGM has been dispatched electronically to the members whose email IDs are registered with the Company/ Depositories.The EOGM Notice is also being made available on the website of the Company at www.vivanzabiosciences.com |
|
Wed, 25 Jan 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication of Financial Results for Quarter Ended December 2022 |
| Tue, 07 Feb 2023 |
High Delivery Percentage
|
Opening at High
|
High Decrease in 1 Month
|
High Decrease in 6 Months
|
High Increase in 5 Years
|
Equities
M.F.
Sectors